CLNN

Clene Inc. - Common Stock (CLNN)

About Clene Inc. - Common Stock (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high

$4.24

Daily low

$3.63

Price at open

$4.04

52 Week High

$11.23

52 Week Low

$3.02

Market cap

58.3M

Dividend yield

Volume

116,947

Avg. volume

82,742

P/E ratio

-1.17

Clene Inc. - Common Stock News